잠시만 기다려 주세요. 로딩중입니다.

Nanotechnology in the arena of cancer immunotherapy

Archives of Pharmacal Research 2020년 43권 1호 p.58 ~ 79
 ( Asadujjaman Md. ) - Chosun University College of Pharmacy

조관형 ( Cho Kwan-Hyung ) - Inje University College of Pharmacy
장동진 ( Jang Dong-Jin ) - Inje University Department of Pharmaceutical Engineering
 ( Kim Joo-Eun ) - Catholic University of Daegu Department of Pharmaceutical Engineering
 ( Jee Jun-Pil ) - Chosun University College of Pharmacy

Abstract


Cancer immunotherapy orchestrates the immune system of the human body to fight against cancer cells. By doing this, it has revolutionized cancer treatment. Toxicities arising from dose-limit and low rates of patient response continue to be the major bottlenecks in clinical outcomes. The immune system has a close relationship with tumor. This leads to the combination of nanotechnology and immunotherapy. Nanotechnology can potentiate the efficacy of immunotherapy by enhancing the delivery and retention, and narrowing the toxicity of immunomodulation. In this regard, immunotherapy can combine with nanomedicine to give strategies that could lessen the side effects and improve clinical outcomes in patient populations. In this review, we explore and recapitulate recent advances in nanoparticle-based cancer immunotherapy.

키워드

Immunotherapy; Peptides; Nucleic acids; Antibodies; Nanotechnology; Nanomedicine
원문 및 링크아웃 정보
 
등재저널 정보